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Abstract 
     Background:  Malta, the smallest island state in 
Europe, with an approximate population of 400,000, has 
one of the lowest reported incidence rates for 
tuberculosis (TB) in its native-born population.1 Long-
term trends for TB among this population were  
investigated. 
     Methods:  A period of 35 years (1979-2013) for the 
Malta-born population was investigated using single-age 
population numbers for each year, retrospective, and 
partly prospective analysis of notified TB cases. Mean 
five-yearly populations were then used to calculate 5-
yearly incidence rates for birth-cohorts, age-groups, 
major site and gender. Annual reported TB incidence 
rates were also calculated.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Results:   In the Malta-born population, over the 35-
year period, reported yearly TB incidence shows a 
downward, albeit decelerating trend. Consecutive 
follow-up of 5-year age-cohorts and 5-year age-groups 
confirms that incidence has fallen, with the highest rates 
being observed in progressively older age-groups. A 
falling trend in TB incidence according major site and 
gender was also observed. 
     Conclusion:  TB is being successfully controlled 
among the Malta-born population, and confirmed to be 
slowly approaching the elimination phase.2  
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Introduction         
     While tuberculosis is a worldwide pandemic, 
incidence varies enormously across populations, 
geographical regions, countries and even within cities.3,4 
The highest reported incidence rates are still seen in sub-
Saharan Africa, while most cases originate from South-
East Asia (35%).  Although global TB incidence has 
been gradually falling since 2002, absolute cases 
numbers had continued to rise until 2006, and are only, 
until recently, recognized to have been falling since that 
year.5 
     The European Centre for Disease Control (ECDC) 
publishes yearly national data on reported TB cases and 
incidence in country populations but not on incidence 
rates in foreign-born populations;1 this may be partly due 
to difficulties in determining a constantly changing or 
unknown denominator population to calculate the 
incidence rate in foreign-born persons.  
     In 2009, Europe representing 5.6% of the global TB 
burden, and is divided into three main geo-political 
regions. These include the European Union (EU) 
including European Economic Area (EEA) countries, the 
Balkans, and the East (former Soviet Union countries 
and Russia). Malta forms part of the former region 
which has the lowest incidence rates of the three; EU 
rates are approximately 15.8 per 100,000 person-years.1 
Reported TB incidence in Malta remains among the 
lowest in Europe, at about 13/100,000 person-years 
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during 20095, despite the increase in absolute number of 
cases diagnosed in Malta after 2001. A relatively large 
influx of irregular migrants, led to a proportional 
increase in the number of cases diagnosed among the 
sub-Saharan population.1,6 
In 1930, the Norwegian Kristian Ardvord was the 
first physician to perform longitudinal cohort analysis 
using country-wide retrospective mortality data to 
investigate epidemiology, using data pertaining to TB. 
He presented a classical study using 5-year aggregate 
data, his discoveries revealed a pattern, enabling him to 
make accurate predictions on future TB mortality rates 
among the populations studied.7  
     This study was our investigation of trends in 
reported incidence rates in a small island population 
similarly using 5-year aggregate data, over the period 
1979 - 2013. Fortunately, TB mortality rates have fallen 
drastically over the years and could not be used, as in the 
study by Ardvord, leading us to investigate a number of 
5-year mean incidence rates in isolation. 
 
Methods     
     Thirty five years of data, from 1979 to 2013 
pertaining to all TB notification for those native-born 
were available and investigated. All data was collected 
from cases seen at the Chest (TB) Clinic at the main 
hospital, including notifications made centrally by 
physicians to Public Health, and cover the whole 
population of Malta. This data was considered highly 
reliable because TB remains a mandatory notifiable 
infection by law, nearly all (98%) patients were followed 
up medically by one Chest Clinic, the number of 
prescribing consultant physicians were strictly limited 
and controlled, anti-TB drugs were cost free for all 
patients and could not be bought on the free market, in 
addition TB drugs are only dispensed by two designated 
government pharmacies. These pharmacies in turn 
inform both Public Health and the Chest Clinic every 
month of anti-TB medications dispensed. The data set 
included all cases considered previously as definite and 
other-than-definite, and nowadays referred to as 
confirmed, probable and possible. A TB case 
specifically refers to new reported cases, diagnosed in 
Malta, among those Malta-born, and commenced on 
standard anti-TB treatment. The denominator 
populations used to calculate all 5-year mean reported 
incidence rates were estimated using the mid-year 
population values obtained from the yearly produced 
single-year tables. These tables provided population 
numbers for each specific age for each year. The source 
of this population data was the official state publication; 
The Yearly Demographic Review of the National 
Statistics Office of Malta.8  
     The original population values for years 1978 to 
1984 were revised in 2000 (following the 1995 census), 
these were considered more accurate than earlier 
estimated values, and were thus used.9 Four cases 
notified in 2003, they were excluded from the official 
data following a request for declassification from the 
diagnosing physician. In retrospect, there was a near 
certainty that their positive cultures were cross-
contaminated, as they were asymptomatic on starting 
treatment and had normal chest x-rays. 
     The thirty five years under review were apportioned 
into seven consecutive 5-year periods, because both 
denominator populations and yearly case numbers were 
small. The 5-year periods were 1979-1983, 1984-1988, 
1989-1993, 1994-1998, 1999-2003, 2004-2008, and 
2009-2013. Each of these 5-year periods were further 
sub-divided according to 5-year age-groups, specifically  
birth to 4 years of age, 5 to 9 years, 10 to 14, 15-19, 20-
24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-
64, 65-69, 70-74, 75-79, 80-84, 85-89, 90-94, and 95 to 
99 years. The mean reported TB incidence for each of 
the separate age-groups in each of the seven 5-year 
periods was calculated using mid-year population 
numbers and 5-year aggregate data. Seven 5-year cross-
sectional studies were produced and merged (figure 2). 
The calculated mean TB incidence for 5-year age 
cohorts, for each of the 5-year periods, was successively 
followed over the 35 years. Similarly, mean incidence 
trends for 5-year age-groups for each of the seven 5-year 
periods were followed. Finally, mean 5-year TB 
incidence was estimated according to major site and 
gender over the study period.  
 
Results 
     During the study period there were a total of 566 
new cases; 368 males and 198 females which included 
378 and 188 cases of pulmonary and non-pulmonary TB 
respectively.  
     The yearly trend in TB incidence (Figure 1) among 
those born in Malta show yearly fluctuations but has 
fallen throughout the thirty five years, resulting in an 
overall pattern resembling that of exponential decay. 
     The combined seven 5-year cross-sectional plots, 
according to 5-year age-groups, of reported TB 
incidence show that incidence has fallen in nearly all 
age-groups and that the higher incidence rates tended to 
occur among progressively older age-groups (Figure 2). 
The resulting composite figure of seven 5-year cross-
sectional plots reveals a general shift downwards and to 
the right.  
Five-year birth cohorts (Figure 3a and 3b) were 
followed over the study period and show a clear fall in 
reported incidence over time, with the exception of the 
1989-1993 period.  Five-year reported incidence in all age-
groups (Figure 4) also show a fall over the same period. 
Five-year reported incidence rates over the 35 years for 
both gender and major site reveal a clear downward trend 
(Figure 5). 
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Figure 1: Yearly TB incidence for the Malta-born population (1979-2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Combined plot of TB incidence for 5-year age-groups for each of the seven 5-year periods 
(Malta-born 1979-2013) 
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Figure 3a: Mean 5-year TB incidence for 5-year birth cohorts for 1979-1983 followed at 5-year intervals 
(Malta-born from 0 to 44 years) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3b: Mean 5-year TB incidence for 5-year birth cohorts for 1979-1983 followed at 5 year intervals.  
(Malta-born 45 to 94 years) 
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Figure 4: Mean 5-year TB incidence for 5-year age-groups for each 5-year period  
(Malta-born  1979-2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Mean 5-year TB incidence according to major site and gender.  
(Malta-born:  1979-2013) 
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Discussion     
     Longitudinal studies examine how data pertaining 
to specific birth cohorts behave over time, and while 
prospective studies are preferred, they are often 
prohibitive due to financial and temporal restraints. In 
contrast, retrospective studies, less hampered by these 
obstacles, are useful when data collection is considered 
reliable, even more so if considered nearly complete, as 
in our case. Analysis of incidence data for specific age-
groups and birth cohorts, which are followed up over 
time, may give a comprehensive picture of changing 
epidemiological trends. The patterns may reveal the 
progression of a disease in a population, and when 
specific interventions might be indicated, they have also 
been shown to possess predictive value.7 In contrast, 
cross-sectional studies examine variables in a 
population, or representative sample, over a specific 
time period. 
     The elimination of tuberculosis is the ultimate goal 
of all National TB Programmes (NTPs). The global aim 
(Millennium Development Goal 6) being the reduction 
of TB prevalence and mortality to half that of 1990 by 
2015, and TB elimination by 2050.7 The first objective 
has been achieved for the Malta-born population. 
Success, in this long-term endeavor in a particular 
population may well be feasible through the consistent 
work of a well-functioning NTP, in conjunction with 
public health and socio-economic measures aimed at 
improving environmental living conditions and 
elimination of poverty.10 WHO had taken the initiative 
through the STOP TB Partnership in launching a new 
global STOP TB strategy for 2011-2015, focusing on 
high quality DOTS expansion and enhancement, control 
of HIV/TB and multi-drug resistance. It also addresses 
the needs of poor and vulnerable populations, 
strengthening of primary health care systems, engaging 
all care providers, and empowering patients and 
communities. The publication also gives an indication of 
the funding required to achieve these goals. It high-lights 
the development and timely adoption of new 
technologies and the need for enabling and promoting 
local research.11 In Malta`s case, the strategy used in the 
past consisted of adopting strategies developed by WHO 
and other larger Western countries, although more 
recently, an official national strategy for Malta has been 
produced.12   
      For epidemiological purposes, a population can be 
considered to be made up of both foreign and native-
born persons; both groups exhibit a host of differing 
dynamics and require appropriate approaches and action.  
Considering that by definition, the national reported TB 
incidence is a combined value of disease arising in both 
native and new entrant populations, elimination of TB, 
even in developed countries is challenging, if not 
impossible to achieve. This is simply because no country 
has complete control over newly-entrant foreign-born 
persons, legal or otherwise, arriving from high-incidence 
countries harbouring either latent or active TB, from 
crossing national borders. In addition, there are no 
interventions which can completely prevent reactivation 
in persons with latent TB. It is recognized that in high-
risk new entrant populations, higher TB reactivation 
rates will occur, similar, if not higher, to rates found in 
their countries of origin. This is highest in the first 2-3 
years from entry, and will continue for many years 
thereafter, albeit at a much lower level.1-2,13  One of the 
main factors pivotal to the success of TB control include 
the political decision to declare the elimination of both 
TB as a national health and social priority. In contrast, 
the greatest danger to TB control is complacency which 
can occur at any and all levels, from patients to health-
care workers to politicians. In addition, falling TB 
incidence can easily tempt administrators to cut on 
funding and prematurely scale down resources with dire 
consequences for TB control. The history of TB control 
in the United States is a case in point.14 
      Figure 1 shows wide fluctuations in reported yearly 
TB incidence, this is probably due to both low case and 
population numbers. This finding is consistent with that 
found in other countries with small populations, 
including Andorra, Iceland, Liechtenstein, Luxemburg, 
and San Marino in contrast to larger populations which 
do not show such large yearly fluctuations.1 Moreover, 
as prevalence falls, one would expect a relative increase 
in non-tuberculous mycobacterial infections,15-16 and an 
increase in the proportion of misdiagnosed TB cases 
relative to actual TB cases. This fact may in part explain 
the reduced rate of decline seen in Figure 1. 
     When comparing incidence, for each of the age-
groups in the seven 5-year periods (Figure 2, and 4), this 
falls consistently over time for the younger age-groups. 
TB among the paediatric age-group is a very good 
indicator (indicator population) of on-going TB infection 
in the community, as they have immature immune 
systems and thus more easily infected and more liable to 
develop disease.17 Analysis in the less-than-19 year age-
group indicates that TB incidence had fallen consistently 
and is similarly low – both being indicators of successful 
national TB control and the actual low levels of TB in 
the community at large.  The higher reported TB 
incidences rates shift to the right, indicating that over 
time TB is being mostly diagnosed in older age-groups 
(Figure 2, and 3b). It is recognised that, in the older 
population immune-senescence causes reactivation and 
is the usual cause of TB in the vast majority of cases.18 
For epidemiological purposes, a population can be 
considered to be made up of both foreign and native-
born persons; both groups exhibit a host of differing 
dynamics and require appropriate approaches and action.   
      Analysis of trends (Figure 1, 3a,3b, 4, and 5) 
7
  
 
 
Original Article 
 
 
 
Malta Medical Journal    Volume 27 Issue 03 2015                                                                                                                
 
 
showed an unexpected peak during the 1989-1993 
period. Examination of yearly incidence (Figure 1) 
indicates that this was a result of unusually high 
incidence occurring in 1992 and 1993 and thus 
influenced data in the 5-year period of 1989-93. This 
may have been due to a combination of factors including 
changes in personnel and case ascertainment, mode of 
diagnosis (clinical, radiological, histological or 
microbiological), cross contamination, a micro-epidemic 
situation or the effect of HIV. It does not seem to have 
been related specifically to major site or gender (Figure 
5), further investigation is indicated. The past and 
present success seen in Malta in reducing TB is multi-
factorial, the main reasons may include, reduction in 
poverty, improvement in housing, centralisation of both 
clinical and pharmaceutical services, standardisation of 
treatment regimes, investigation, drug treatment, follow-
up, compliance, and close contact screening, all of which 
were and still remain cost free for all. In addition, anti-
TB drugs were and remain unavailable on the private 
market, thus eliminating the problem of unrecorded 
diagnosis and treatment of cases. It must be noted that 
no increase in incidence occurred after 2001, when the 
massive influx of new irregular entrant cases started. 
Investigating the epidemiology of foreign-born TB was 
not an objective of the present study, and was 
specifically excluded to obtain a clearer epidemiological 
picture prevailing in the local population. 
     
Limitations of the study
    
Data collection was mainly retrospective, and case 
numbers and populations were both small, although the 
data was considered nearly complete and reliable for 
reasons alluded to above. The cases studied included 
confirmed, probable and possible cases, thus clinical, 
radiological, histological and microbiological over 
diagnosis, may have occurred. This was strongly 
suspected to have occurred at least in 2003 and involved 
four cases. DNA fingerprinting in Malta was not 
performed prior to 2006, thus, the possibility of cross-
contamination of samples before this date should be 
considered. In addition, a number of cases which were 
diagnosed with TB from smear positive but negative 
culture results may have actually had an environmental 
mycobacterium infection. In fact, in  recent years, 
approximately 75 % of positive cultures in smear 
positive cases were non-tuberculosis in origin.  
 
Further study   
The high number of cases which occurred in 1992 
and 1993 should be investigated further. As prevalence 
continues to fall, the proportion of false positive 
diagnoses may increase, moreover the impact of 
imported TB with often drug resistance, on the native 
population and the increase of non-tuberculous 
mycobacterial infections will require particular attention 
and continued epidemiological monitoring. 
 
Conclusion  
It has been shown that trends in TB epidemiology, 
in small populations with very low levels of TB, can still 
be investigated using 5-year aggregate data. Trends in 
TB incidence in the native population in Malta, 
continues to fall, albeit at a slower rate, while TB is 
being diagnosed more often in progressively older 
patient cohorts.  TB elimination in Malta, at least in the 
native population, despite rising national incidence, still 
remains an achievable goal. 
 
Key points 
• Epidemiological portraits were produced using 5-
year aggregate data.  
• An alternative methodology (compared to analysis 
of yearly data) concerning TB epidemiological 
dynamics in small populations with very low 
incidence, approaching the elimination phase has 
been described. 
• It was possible to show falling trends for 5-year 
age-groups, birth cohorts, major site, and gender 
among a whole native population with very low TB 
incidence. 
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